Chemist Shama Mirza and her team only meant to research methods to determine which patients with a certain type of cancer called glioblastoma might respond well to chemotherapy treatment. Instead, they found a compound that could unlock new avenues of treatment for glioblastoma – the same type of cancer that took the life of U.S. Senator John McCain.

“‘Knowing who would benefit from the treatments and who
would not – that is the guessing game we are playing
now… But, if the results of human trials agree
with our current findings, it’s going to be huge for these
patients.’”
 
Read the full article in In Focus >